Skip to main content

Table 6 No. of patients and institutions treated with perioperative denosumab for GCTBa

From: Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study

Timing of perioperative denosumab No. of patients (%) No. of institutions (%)
Preoperative only 21 (53%) 10 (63%)
Postoperative only 9 (23%) 5 (31%)
Both pre- and postoperative 10 (25%) 5 (31%)
Total 40 16*
  1. aGCTB, giant cell tumor of bone
  2. *Some institutions performed denosumab at different timing